Nureca Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Nureca Quarterly Results    (NRCA)

Here are the latest quarterly results of Nureca. For more details, see the Nureca financial fact sheet and Nureca share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Nureca Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m318 
Other income Rs m13 
Turnover Rs m331 
Expenses Rs m275 
Gross profit Rs m44 
Depreciation Rs m1 
Interest Rs m4 
Profit before tax Rs m52 
Tax Rs m13 
Profit after tax Rs m39 
Gross profit margin %13.7 
Effective tax rate %25.2 
Net profit margin %12.2 
Diluted EPS Rs 3.9  
Diluted EPS (TTM) Rs NA  
 Subscriber Feature    
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Trading Company Quarterly Results:   VIVANZA BIOSCIENCES  SYNCOM FORMULATIONS  NORRIS MEDICINES  ALKEM LABORATORIES  SUVEN LIFE SCIENCES  

Compare NURECA With:   VIVANZA BIOSCIENCES  SYNCOM FORMULATIONS  NORRIS MEDICINES  ALKEM LABORATORIES  SUVEN LIFE SCIENCES  



Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NURECA SHARE PRICE


Jul 23, 2021 (Close)

TRACK NURECA

MORE ON NURECA

NURECA - VISHVA PRABHA COMPARISON

COMPARE NURECA WITH

MARKET STATS